Cause of death, by non-communicable diseases, female in Suriname
Suriname: Cause of death, by non-communicable diseases, female was 60.5% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, female in Suriname, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths.
Analysis
In 2021, cause of death, by non-communicable diseases, female in Suriname stood at 60.5%. That is the lowest value across all 6 years on record.
The figure is down 23.6% on the previous year and down 19.1% over ten years.
Over the whole period, cause of death, by non-communicable diseases, female in Suriname peaked at 80.4% in 2019 and was at its lowest, 60.5%, in 2021.
That places Suriname 122nd out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, female in Suriname, year by year
| Year | % of total female deaths | Change |
|---|---|---|
| 2000 | 65.1% | — |
| 2010 | 74.8% | +14.9% |
| 2015 | 79.8% | +6.7% |
| 2019 | 80.4% | +0.8% |
| 2020 | 79.1% | -1.6% |
| 2021 | 60.5% | -23.6% |
Suriname compared with similar countries
- Suriname's 60.5% is below the median for upper middle income countries, which is 70.0%, 86% of the median. (55 countries reporting)
- Suriname's 60.5% is below the median for Latin America & Caribbean, which is 65.2%, 93% of the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 65.1% | 65.1% | 65.1% | 1 |
| 2010s | 78.3% | 74.8% | 80.4% | 3 |
| 2020s | 69.8% | 60.5% | 79.1% | 2 |
Countries ranked near Suriname
More health data for Suriname
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6063 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,195 deaths per 1,000 people (2090)
- Number of infants who die before age 1 22 deaths (2100)
- Population ages 00-04, female, annual growth rate 0.0344 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0409 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.0221 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0425 units per person (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, female in Suriname?
- Cause of death, by non-communicable diseases, female in Suriname was 60.5% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, female recorded in Suriname?
- The highest recorded value was 80.4% in 2019.
- What is the lowest cause of death, by non-communicable diseases, female recorded in Suriname?
- The lowest recorded value was 60.5% in 2021.
- How does Suriname rank for cause of death, by non-communicable diseases, female?
- Suriname ranks 122nd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, female rising or falling in Suriname?
- Over the last ten years it is down 19.1%. The long-run trend across the full record is rising.
- Where does this Suriname data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.